Professional Experience
Dr. Lohi has made significant contributions to both clinical practice and medical education:
- Chief Physician, Department of Pediatric Hematology and Oncology, Tampere University Hospital (Tays)
- Professor, Pediatric Hematology and Oncology, Tampere University
- Research Director, TamCAM
- Founder, Pediatric Clinical Trials Unit (PeeTU), Tampere (2017)
- Recipient, Cancer Doctor of the Year 2024, Cancer Foundation Finland
Academic Contributions
Dr. Lohi’s academic endeavors focus on pediatric cancer research and education:
- Research Focus: Mechanisms of childhood acute leukemia and development of targeted therapies
- Leadership: Director of HemoRes research group at Tays Cancer Centre
- Teaching: Educator in pediatric hematology and oncology at Tampere University
- Publications: Over 140 peer-reviewed articles and numerous conference presentations
Areas of Expertise
Dr. Lohi specializes in:
- Acute Leukemia: Diagnosis and treatment of childhood acute lymphoblastic leukemia (ALL)
- Hematology: Management of various pediatric blood disorders
- Oncology: Treatment of solid tumors in children
- Clinical Research: Development of personalized treatment protocols and clinical trials
Publications and Research
Dr. Lohi has contributed extensively to pediatric hematology and oncology literature:
- ResearchGate Profile: Over 140 publications with significant citations
- Google Scholar: Extensive list of peer-reviewed articles in pediatric oncology
- Research Interests: Mechanisms of childhood acute leukemia, targeted therapies, and clinical trial design
Patient Care Philosophy
Dr. Lohi is committed to providing compassionate and comprehensive care:
- Holistic Approach: Addresses both physical and emotional needs of patients
- Patient Communication: Explains complex medical information in an understandable manner
- Empathy: Recognized for his humanity and patient-centered care
- International Patients: Open to consultations and treatment for international patients
Professional Affiliations
Dr. Lohi is affiliated with several esteemed organizations:
- Finnish Medical Association: Member
- European Society for Pediatric Hematology and Oncology (ESPHO): Member
- Finnish Pediatric Research Foundation: Supporter and collaborator
- Board Certifications: Certified in Pediatric Hematology and Oncology in Finland
FAQs
- Is Dr. Olli Lohi board-certified?
- Yes, Dr. Lohi is board-certified in Pediatric Hematology and Oncology in Finland.
- What types of surgeries does he perform?
- Dr. Lohi specializes in non-surgical treatments for pediatric blood cancers and solid tumors, focusing on chemotherapy and targeted therapies.
- Does he treat international patients?
- Yes, Dr. Lohi is open to consultations and treatment for international patients, offering expertise in pediatric hematology and oncology.
- How long is the typical hospital stay?
- The length of hospital stay varies depending on the specific treatment plan, ranging from outpatient visits to extended inpatient care.
- What languages does he speak?
- Dr. Lohi is fluent in Finnish and English, facilitating communication with a broad patient base.
